Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05824585
Title DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dizal Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research site NOT_YET_RECRUITING New York New York 10065 United States Details
Research site RECRUITING Albury New South Wales Australia Details
Research site NOT_YET_RECRUITING Ballarat Victoria Australia Details
Research site RECRUITING Melbourne Victoria Australia Details
Research site RECRUITING Perth Western Australia Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field